Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [11313]

Novel theranostic tool allows for noninvasive identification and treatment of ovarian cancer

Novel theranostic tool allows for noninvasive identification and treatment of ovarian cancer

EAU 2024: Five-year interval is safe for prostate cancer screening, research shows

EAU 2024: Five-year interval is safe for prostate cancer screening, research shows

New study targets major risk factor for gastric cancer

New study targets major risk factor for gastric cancer

Researchers awarded grant to develop genetic risk score for thyroid cancer

Researchers awarded grant to develop genetic risk score for thyroid cancer

Soluble immune checkpoint factors in blood as potential biomarkers of therapeutic efficacy for ICI cancer immunotherapy and assessing t-cell exhaustion

Soluble immune checkpoint factors in blood as potential biomarkers of therapeutic efficacy for ICI cancer...

Prolonged use of certain hormone drugs linked to increased brain tumour risk

Prolonged use of certain hormone drugs linked to increased brain tumour risk

Researchers create new tool for assessing risk of kidney injury after chemotherapy

Researchers create new tool for assessing risk of kidney injury after chemotherapy

Beating by overheating: new strategy to combat cancer

Beating by overheating: new strategy to combat cancer

Liver fibrosis, non-parenchymal cells, and the promise of exosome therapy

Liver fibrosis, non-parenchymal cells, and the promise of exosome therapy

Combining epigenetic cancer medications may have benefit for colorectal cancers and other tumour types

Combining epigenetic cancer medications may have benefit for colorectal cancers and other tumour types

More from ecancer